IRESSA
NDC 0310-0482, Gefitinib, tablet, coated, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-0482
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA206995
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0482 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEFITINIB250 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-0482-30 | 00310048230 | 30 TABLET, COATED in 1 BOTTLE (0310-0482-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/827d60e8-7e07-41b7-c28b-49ef1c4a5a41
Use it
Look up 0310-0482 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0482 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-0482. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.